At a glance
ClinicalIndex Comparison RecordN/ACompleted· 55 enrolled
Drug / intervention
Acoustic Radiation Force Imagingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Determination of Liver Stiffness in Chronic Liver Disease Patients by Acoustic Radiation Force Imaging (ARFI) Ultrasound
Children's Hospital Medical Center, Cincinnati·interventional·Posted Jan 11, 2016·Updated Jul 12, 2017
In Brief
A clinical study evaluating Acoustic Radiation Force Imaging for Chronic Liver Disease. Completed, enrolled 55 participants.
Detailed Summary
A prospective, pilot study using acoustic radiation force imaging (ARFI) ultrasound (US) to quantify liver stiffness in children and young adults with chronic liver disease. ARFI results will be compared to the current clinical standard of Magnetic Resonance Elastography (MRE) and to liver biopsy when available.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Liver Disease
Countries--
CollaboratorsSiemens Medical Solutions
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
Primary CompletionDec 2015
First PostedJan 2016
Study CompletionMay 2016
TodayJul 2026
First PostedJan 11, 2016
Enrollment StartJun 1, 2014
Primary CompletionDec 1, 2015
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 10.5 years ago
Interventions
Acoustic Radiation Force Imagingdevice
ARFI US is a novel technique, recently FDA approved for use in children and adults, which provides an alternative method for quantifying liver stiffness.